MINI FUTURE LONG - IPSEN | Market Closed - Euronext Paris 10:00:01 03/06/2024 pm IST | ||
| 1.51 EUR | +4.14% |
|
| Current month | +4.14% | ||
| 1 month | +34.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 1.51 | +4.14% |
| 31/24/31 | 1.45 | +3.94% |
| 30/24/30 | 1.395 | +1.45% |
| 29/24/29 | 1.375 | +2.23% |
| 28/24/28 | 1.345 | -7.24% |
Real-time Euronext Paris
Last update June 03, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
BNP Paribas
|
| J71HB | |
| ISIN | FRBNPP04H315 |
| Date issued | 05/07/2022 |
| Strike | 92.32 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.46 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.155 € |
|---|---|
| Lowest since issue | 0.3 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.6
EUR
Average target price
126.4
EUR
Spread / Average Target
+4.81%
- Stock Market
- Certificates
- J71HB Certificat
